Sleep quality, inflammation and early morning activity: all may influence mental health

Poor sleep is a modifiable risk factor linked to depression, schizophrenia, and chronic physical diseases – and inflammation may be a mediating factor. APAAM 2021 also heard  evidence suggesting that intervention to improve Morning Activity Disorder (MAD) may be a very sane idea.

“Difficulty getting going”, is how many of us describe not being a morning person. Morning Activation Deficit (MAD) is a more technical description. Whatever the terminology, the phenomenon is frequent in depression.1,2

It has been thought that lack of early morning activation is a consequence of depression, but perhaps the reverse is true: depression could be a result of lack of morning activation. If so, encouraging morning activity through scheduling tasks may be a helpful therapeutic approach, suggested Stephen Smagula (University of Pittsburgh, USA). 

Low morning activity may lead to depression by allowing more time for thinking about negative emotional content

 

A neurobiological basis in rumination  

Evidence for the hypothesis comes from people who care for patients with dementia and are at risk of depression. Carers with mild-moderate symptoms were compared with those who had few or none.

  • Actigraphy data confirmed the association between morning inactivity and depression: carers with depressive symptoms were significantly less active than controls, but only during the period  8-10 am.3
  • Morning inactivity predicted the persistence of depressive symptoms six months later. Carers with active mornings seemed to be protected against developing symptoms.3
  • Support for a neurobiological basis came from functional MRI. “Non-morning”carers had greater resting-state connectivity between the amygdala (involved in fear and stress responses) and the ventral posterior cingulate cortex (involved in autobiographical memory) than morning-type carers.4 Greater amygdala-cingulate connectivity correlated with depressive symptoms.

This pathway may be related to rumination, Professor Smagula speculated. Lack of morning physical activity could contribute to depression by allowing more time for thinking about negative emotional content.

Intervention based on this hypothesis is feasible, he continued. In a pilot study in ten caregivers, therapist-led activity scheduling and monitoring for nine weeks led to a decrease in self-reported morning activity deficits. 

In schizophrenia, the interface between disturbed sleep, inflammation and aging is a new target for intervention

 

Poor sleep a modifiable factor related to excess mortality

The fifteen-year (and growing) gulf in life expectancy between people with and without schizophrenia arises largely from a greater susceptibility to chronic diseases of aging,5 Ellen Lee (University of California San Diego, USA) told the session on sleep and mental health.

Inflammatory processes have been implicated in this earlier onset of age-related pathology (or “inflammaging”) in people with schizophrenia. And poor sleep seems to contribute, she said. Sleep problems affect 30-80% of people with schizophrenia, precede the onset of symptoms, and are associated with worse quality of life and cognitive function.6

Baseline data on a longitudinal cohort of people with schizophrenia and controls cast light on these associations:6

Findings implicate poor sleep and inflammation in cognitive and metabolic dysfunction

  • Compared with controls, people with schizophrenia slept longer and had poorer sleep quality
  • In people with schizophrenia, poor sleep quality was associated with higher levels of the inflammatory markers C-reactive protein and interleukin-6
  • High marker levels were associated with slower cognitive processing, even in the absence of insomnia
  • Both poor sleep and raised CRP and IL-6 were more frequent in women than men
  • There is a suggestion that poor sleep is associated with metabolic dysfunction evident in higher levels of HbA1c.

Preliminary data also suggest that obstructive sleep apnea is common among people with schizophrenia in the San Diego cohort. It was found in 48% of subjects, but only 6% had been formally diagnosed. Sleep apnea in the study was associated with inflammation and slower processing.

 

For the latest updates on sea.progress.im, subscribe to our Telegram Channel https://bit.ly/telePiM

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References

1. Hasler BP. Morningness-eveningness and depression: Preliminary evidence for the role of BAS and positive affect. Psychiatry Res. 2010 ; 176: 166–73

2. Van den Berg JF et al. Chronotype and depressive symptoms in students: An investigation of possible mechanisms, Chronobiology International 2018 35:1248-61

3. Smagula SF et al. Activity patterns related to depression symptoms in stressed dementia caregivers. Int Psychogeriatrics 2019; Oct 29;1-8.doi: 10.1017/S1041610219001601

4.  Smagula SF et al. Resting-state function connectivity associated with being a "morning-type" dementia caregiver and having lower depression symptom severity. Gerontol B Psychol Sci Soc Sci 2020 Aug 5;gbaa115

5. Lee EE et al. A widening longevity gap between people with schizophrenia and general population: A literature review and call for action. Schizophr Res 2018; 196:9-13

6. Lee EE et al. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences. Am J Geriatric Psychiatry 2018; October 11, 2018DOI:https://doi.org/10

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country